Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
PQQ has previously been shown to exert cardioprotective activity in the context of myocardial infarction (Zhu et al., 2004), diabetic cardiomyopathy (Qu et al., 2022), lipid abnormalities (Bauerly et al., 2011), and COVID-19 mRNA vaccine-related cardiac inflammation (Boretti, 2022)
However, these effects are much smaller and shorter-lasting than those of GLP-1 medications and shouldnt be considered a replacement for treatment.
Clinical Gastroenterology, 30(2), 145159
and the IARC Group 1 carcinogen c-Met red flag and why cleaner air comes first, not a peptide
Eventide was an injection-free GLP-1 agonist that showed promise, but ultimately didnt get FDA approval for its application to treat type 2 diabetes
US$ 26.93
US$ 21.35
)
US$ 22.72
